Clinical Trial Update: A Comparison of Exenatide and Insulin Glargine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Exenatide and Insulin Glargine in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED